S. Ullrich
Infectious Diseases · 2020
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Infectious Diseases — 44 citations into it
Whom S. Ullrich trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from S. Ullrich's perspective
Ordered by how strongly the researchers S. Ullrich trusts endorse each paper. Same corpus, a different order for every researcher.
- The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor (Proceedings of the National Academy of Sciences of the United States of America)
- Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs (Science)
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 (New England Journal of Medicine)
- The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China (Journal of Autoimmunity)
- Virus-encoded proteinases and proteolytic processing in the Nidovirales. (Journal of General Virology)
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China (Science)
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro (Cell Research)
- Coronavirus as a possible cause of severe acute respiratory syndrome (The Lancet)
- Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. (New England Journal of Medicine)
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury (The Lancet)
Their papers
- The SARS-CoV-2 main protease as drug target (2020) — 635 citations